CSPC Pharmaceutical Group Ltd. (CHPTY) Raised to Hold at Zacks Investment Research
CSPC Pharmaceutical Group Ltd. (OTCMKTS:CHPTY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Thursday.
According to Zacks, “CSPC Pharmaceutical Group Limited operates as a pharmaceutical group in China. Its bulk drug products include vitamin C, penicillin G and 7-ACA. The Company is also a major manufacturer of antibiotic finished drugs such as penicillin and cephalosporin products. CSPC Pharmaceutical Group Limited, formerly known as China Pharmaceutical Group Limited, is based in Wan Chai, Hong Kong. “
CSPC Pharmaceutical Group (OTCMKTS CHPTY) remained flat at $$97.96 during midday trading on Thursday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.44 and a current ratio of 1.95. CSPC Pharmaceutical Group has a twelve month low of $51.99 and a twelve month high of $97.96. The firm has a market cap of $12,230.00, a P/E ratio of 38.57, a PEG ratio of 1.19 and a beta of 1.31.
TRADEMARK VIOLATION NOTICE: “CSPC Pharmaceutical Group Ltd. (CHPTY) Raised to Hold at Zacks Investment Research” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/cspc-pharmaceutical-group-ltd-chpty-raised-to-hold-at-zacks-investment-research/1708080.html.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs).
Receive News & Ratings for CSPC Pharmaceutical Group Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.